 DUBLIN, Ireland and TREVOSE, Pa., Feb. 25, 2021 GLOBE NEWSWIRE -- Strongbridge Biopharma plc, Nasdaq: SBBP, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it will host a conference call with members of Strongbridges management team on Wednesday, March 3, 2021 at 8:30 a.m. ET to discuss the Companys fourth quarter and full-year 2020 financial results and corporate highlights. The conference call will follow the anticipated release of the Companys financial results earlier that day. 